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Abstract 
Treatment of isolated mitochondria with Ca 2+ and inorganic phosphate (P~) induces an inner membrane permeability that appears to 
be mediated through a cyclosporin A (CsA)-inhibitable Ca2+-dependent pore. Isolated mitochondria during inner membrane permeability 
undergo rapid effiux of matrix solutes such as glutathione as GSH and Ca 2+, loss of coupled functions, and large amplitude swelling. 
Permeability transition without large amplitude swelling, a parameter often used to assess inner membrane permeability, has been 
observed. The addition of either oligomycin, antimycin, or sulfide to incubation buffer containing Ca 2÷ and Pi abolished large amplitude 
swelling of mitochondria. The GSH status during a Ca 2÷- and P~-dependent mechanism of mitochondrial GSH release in isolated 
mitochondria was influenced significantly by metabolic inhibitors of the respiratory chain but did not prevent inner membrane 
permeability as demonstrated by the release of mitochondrial GSH and Ca 2+. The release of GSH was inhibited by the addition of CsA, a 
potent inhibitor of permeability transition. Under these conditions we did not find GSSG; however, rapid oxidation of pyridine 
nucleotides and depletion of ATP and ADP with conversion to AMP occurred. The addition of CsA, prevented the oxidation of pyridine 
nucleotides and depletion of ATP and ADP. Since NADH and NADPH were extensively oxidized, protection against oxidative stress is 
reflected in maintenance of GSH and not observable lipid peroxidation. Evidence from transmission electron microscopy analysis, 
combined with the GSH release data, indicate that permeability transition can be observed in the absence of large amplitude swelling. 
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1. Introduction 
Without mitochondrial antioxidant defense systems uch 
as the glutathione redox cycle, aerobic metabolism, an 
essential process for life in many species, would likely be 
impossible due to the endogenous formation of reactive 
oxygen species (ROS). It is estimated that nearly 90% of 
the total 02 consumed by mammalian species is delivered 
to mitochondria, where a four-electron reduction to H20 
by the respiratory chain is coupled to ATP synthesis [1,2]. 
Nearly 4% of mitochondrial 02 is incompletely reduced, 
due to leakage of electrons along the respiratory chain, 
forming ROS such as the superoxide radical (O2), hydro- 
gen peroxide (H202), singlet oxygen, and hydroxyl radical 
(HO)  [1-51. 
Mitochondrial GSH is critical to cell viability, espe- 
cially under experimental conditions involving a disruption 
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of cellular Ca 2 + homeostasis [6-10]. Only 10-15% of the 
cellular GSH resides in liver mitochondria, where it is 
concentrated (10 mM vs. 7 mM in the cytosol) [11] and 
functions in cellular defense against reactive oxygen 
species, particularly H202 [8,12]. Since liver mitochondria 
do not contain catalase [6], detoxification of H202 occurs 
through the GSH peroxidase/reductase redox cycle [ 13,14]. 
Loss of mitochondrial GSH could therefore be detrimental 
to viability, particularly if challenged oxidatively. 
We have previously demonstrated a Ca 2+ dependent 
mechanism for the rapid and nearly complete depletion of 
mitochondrial GSH. Treatment of isolated mitochondria 
with Ca 2+ and P~ permeabilizes the inner membrane of 
mitochondria, releasing small matrix solutes such as GSH 
and Ca 2+ [15-19]. This permeability transition is thought 
to occur through activation or perhaps deregulation by 
Ca 2+ and Pi of an inner membrane protein that functions 
as a putative pore. Following permeabilization, mito- 
chondria undergo large amplitude swelling. Both inner 
membrane permeability and swelling are prevented by 
nanomolar concentrations of the immunosuppressive cyclic 
peptide, CsA [15,16,20,21]. 
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The transport of Ca 2+ by mitochondria s driven by the 
transmembrane potential [22-25]. The inward movement 
of Ca 2+ decreases the transmembrane potential which is 
restored either by increasing respiratory chain activity or 
ATP hydrolysis. Since mitochondrial Ca 2+ uptake is 
closely linked with permeability transition, we examined 
the effects of treatment with the metabolic inhibitors, 
antimycin, oligomycin and sulfide, on inner membrane 
permeability and large amplitude swelling. Antimycin A 
and sulfide are electron transport inhibitors at complex III 
and cytochrome oxidase, respectively. Oligomycin inhibits 
ATP synthase and eventually prevents electron transport 
by coupled mitochondria [25]. 
We have recently reported in a short communication 
that, during Ca 2÷ and Pi-induced permeability transition, 
both NADH and NADPH are extensively oxidized and 
ATP and ADP are depleted within several minutes [26]. 
This is a novel finding, since Pi-induced permeability 
transition was not previously thought to alter pyridine 
nucleotide ratios or adenine nucleotide status. We have 
also observed conditions in which inner membrane perme- 
ability occurs without large amplitude swelling but with 
loss of calcium and membrane potential [27]. These condi- 
tions were observed when mitochondria were treated with 
either antimycin, oligomycin or sulfide in combination 
with Ca 2 + and Pi [27]. 
Since NAD(H) or NADP(H) (700-835 Da) are nor- 
mally impermeable to the inner membrane, the possible 
release of these molecules, as well as glutathione, has been 
examined uring Ca 2+- and P~-induced permeability transi- 
tion. In addition, we have determined some aspects of the 
status of both pyridine and adenine nucleotides following 
treatment with either antimycin, oligomycin or sulfide 
during Ca 2+- and Pi-induced permeability transition. 
rats (325-375 g) (Simonsen Labs, Gilroy, CA) were ex- 
cised and homogenized in isolation buffer containing 220 
mM mannitol, 70 mM sucrose, 2 mM Hepes, 0.5 mM 
EGTA, and 0.5 mg/ml bovine serum albumin (pH 7.4). 
Mitochondria were washed twice in isolation buffer devoid 
of EGTA (pH 7.0). After the final wash, the mitochondrial 
pellets were suspended (25-30 mg/ml) in incubation 
buffer containing 213 mM mannitol, 71 mM sucrose, 10 
mM succinate, and 3 mM Hepes (pH 7.0). Mitochondria 
prepared by this method contained approx. 10 nmol 
Ca2+/mg protein. Mitochondrial protein was determined 
spectrophotometrically by the method of Bradford [29] 
with bovine serum albumin as the standard. 
2.3. Mimchondrial incubations 
Mitochondria (1 mg protein/ml) were added to 10-ml 
Erlenmeyer flasks containing incubation buffer plus the 
various treatments described in the figure legends. After 
briefly swirling the flask, 1.0 ml samples were taken 
immediately following the addition of mitochondria. These 
samples constitute the initial time points. Mitochondrial 
suspensions were exposed to atmospheric air throughout 
the remainder of the incubation period. Samples (1 ml) of 
mitochondrial suspensions, taken at the times indicated in 
the figure legends, were transferred to 1.5-ml microcentri- 
fuge tubes and immediately centrifuged for 30 s at 13 000 
X g. The supernatants were removed for further biochemi- 
cal analysis where indicated. The remaining mitochondrial 
pellets were resuspended in either 10% perchloric acid 
(PCA) and analyzed for GSH, GSSG, adenine and oxi- 
dized pyridine nucleotides or in 0.5 M KOH in 50% 
ethanol and 0.35% cesium chloride for the analysis of 
reduced pyridine nucleotides as described below. 
2. Materials and methods 
2.1. Materials 
All chemicals were purchased from commercial sources 
and were of the highest quality available. CsA was a 
generous gift from Dr. Susan Kohlhepp (Providence Hos- 
pital, Portland, OR). CsA was dissolved in 100% ethanol 
(0.5 mM stock) and stored at 4 ° C. Oligomycin (A,B,C), 
antimycin A, and sodium sulfide were purchased from 
Sigma Chemical Company (St. Louis, MO). Aqueous tock 
solutions of sodium sulfide (0.5 M) were prepared the day 
of each experiment. Stock solutions of oligomycin (3 mM) 
and antimycin (1 mM) were dissolved in ethanol. 
2.2. Preparation of  mitochondria 
Isolated mitochondria were prepared by differential cen- 
trifugation according to the method of Schnaitman and 
Greenwalt [28]. Briefly, livers from male Sprague-Dawley 
2.4. Biochemical analysis 
GSH was determined by HPLC analysis according to 
the method of Reed et al. [30] with modifications as 
described previously [15]. Large amplitude swelling was 
assessed spectrophotometrically by monitoring the ab- 
sorbance at 540 nm with an Aminco DW 2000 spectro- 
photometer operated in split-beam mode of mitochondrial 
suspensions [31]. Dose concentration of each metabolic 
inhibitor to be used was established on the basis of their 
effect on swelling. 
Intra- and extra-mitochondrial pyridine and adenine nu- 
cleotides were measured according to the HPLC method of 
Jones [32] with the following modifications to accommo- 
date mitochondrial samples. Briefly, 1 ml samples contain- 
ing 1 mg protein were removed from the incubation flask 
at the appropriate time point, transferred to microcentri- 
fuge tubes and centrifuged at 13000Xg for 30 s to 
separate the suspended mitochondria from the incubation 
buffer. A sample (0.500 ml) of the supernatant (extra-mito- 
chondrial) was transferred to microcentrifuge tubes con- 
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taining either 0.100 ml 10% perchloric acid (PCA) for the 
analysis of ATP, ADP, AMP, NADP + and NAD + or 
0.100 ml 0.5 M KOH in 50% ethanol and 0.35% cesium 
chloride for the analysis of NADH and NADPH, and then 
frozen immediately at -80  ° C. The mitochondrial pellets 
were suspended in either 0.500 ml 10% PCA for extraction 
of intramitochondrial ATP, ADP, AMP, NADP +, and 
NAD + or 0.100 ml 0.5 M KOH in 50% ethanol and 0.35% 
cesium chloride for extraction of NADPH and NADH. The 
samples were immediately iced for 15 min, sonicated for 5 
s, and then frozen at -80  ° C. Prior to analysis, samples 
were thawed, the acid extracted samples neutralized with 
10 mM KOH and 1 M KH 2 PO4, centrifuged at 13 000 x g 
for 30 s to remove insoluble debris, and assayed for either 
NADH and NADPH (base extraction) or NAD +, NADP +, 
ATP, ADP, and AMP (acid extraction). All samples were 
assayed by HPLC within 24 h of collection. 
2.5. Transmission Electron Microscopy (TEM) analysis 
Samples (1 mg) for TEM were fixed in 3.0% glu- 
taraldehyde (pH 7.2) for approx. 4 h. Mitochondria were 
allowed to settle out by gravity and rinsed twice with 0.2 
M sodium cacodylate buffer. The rinsed samples were 
centrifuged at 12500 X g for 10 min. Following centrif- 
ugation, the pellet was gently removed and minced into 
pieces, 1 mm 3. Samples were postfixed in 1.0% OsO 4 for 
1 h, rinsed through a graded acetone series, infiltrated 
with, and embedded in, epoxy resin. Ultrathin sections 
(60-80 nm) were cut and stained with uranyl acetate and 
bismuth subnitrate. Specimens were examined with a Ziess 
EM 10/A transmission electron microscope at an acceler- 
ating voltage of 60 kV. 
3. Results 
3.1. Effect of metabolic inhibitors on GSH, mitochondrial 
large amplitude swelling and mitochondrial u trastructure 
during permeabili~ transition 
We have previously reported [15] that during treatment 
with 70 IzM Ca 2+ and 3 mM Pi (CaPi), isolated mito- 
chondria rapidly ( < 5 min) release approx. 100% of matrix 
GSH by a CsA-sensitive mechanism. Since the addition of 
antimycin, sulfide or oligomycin prevented large-ampli- 
tude swelling associated with CaPi-induced permeability 
transition, we determined the status of mitochondrial GSH 
under these conditions. As shown in Table 1, treatment 
with CaP~ resulted in a rapid loss of matrix GSH, as 
previously reported [15]. The addition of either 0.5 mM 
sulfide, 3 tzM oligomycin, or 1 p,M antimycin to CaP c 
treated mitochondria ameliorated CaPi-induced loss of ma- 
trix glutathione to varying degrees. The presence of sulfide 
or oligomycin to CaPi-treated mitochondria nhibited GSH 
loss more potently than treatment with antimycin (Table 
1). The lost GSH was recovered in the extramitochondrial 
buffer as GSH (data not shown). To determine whether the 
release of mitochondrial GSH observed following treat- 
ment with CaP~ plus either oligomycin, antimycin or sul- 
fide (Table 1) occurred through the permeability transition 
mechanism, 0.5 /zM CsA was included in the incubation. 
The addition of 0.5 /zM CsA prevented the release of 
mitochondrial GSH under these conditions (data not 
shown). 
Incubation of mitochondria with CaP i resulted in the 
rapid decrease in absorbance at540 nm due to large-ampli- 
tude swelling [15,16]. Addition of 0.5 /zM CsA, a potent 
inhibitor of the permeability transition, prevented the 
large-amplitude swelling induced by CaP i [15,16]. Simi- 
larly, the addition of either 0.5 mM sulfide, 3 p.M 
oligomycin, or 1 tzM antimycin also inhibited CaPi-in- 
duced large-amplitude swelling that is generally associated 
with the permeability ransition [27]. Since large-amplitude 
swelling was not observed in mitochondria treated with 
CaP i plus the metabolic inhibitors [27], although inner 
membrane permeability was observed as indicated by the 
CsA-sensitive release of GSH (Table 1), samples were 
prepared and analyzed by TEM to determine whether 
morphological changes could be observed under these 
conditions. Fig. l a shows untreated mitochondria follow- 
ing a 10 min incubation. They have an electron-dense and 
well-defined ultrastructure, indicating they are functionally 
and structurally intact and highly energized [33]. 
Fig. l b shows mitochondria undergoing the permeabil- 
Table 1 
Effect of metabolic inhibitors on the status of glutathione, pyridine nucleotides, and energy charge during calcium and inorganic phosphate-induced 
permeability transition in mitochondria solated from rat liver 
Treatment Percent GSH NAD:NADH NADP:NADPH Energy 
release at 10 min 5 min 5 min Charge 
Control 0 0.20 0.074 0.351 
CaP i 95 1.00 1.038 0.158 
CaP i + CsA 0 0.17 0.127 0.479 
CaP i + oligomycin 65 0.39 0.308 0.409 
CaP i + sulfide 27 0.63 0.700 0.209 
CaP i + antimycin 73 1.36 2.020 0.169 
Mitochondria (1 mg/ml) were incubated in the absence (control) or presence of either 70 /.LM Ca 2 + and 3 mM Pi (CaPi); 0.5/zM CsA plus Ca Pi; 0.5 mM 
sulfide plus CaP i (sulfide + CaPi); 3 ~M oligomycin plus CaP i (oligomycin + CaPi); or 1 /xM antimycin plus CaP, (antimycin + CaPi). Samples (1 ml) 
were taken at the various times indicated and analyzed for GSH, pyridine and adenine nucleotides as described in Section 2, n = 3-4 _+ SE. 
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Fig. 1. Ultrastructure of mitochondria treated in the absence and presence of metabolic inhibitors during the permeability ransition. Mitochondria (1 
mg/ml) were prepared for TEM analysis as described in Section 2. (a) Control (untreated mitochondria following a 10 min incubation i  incubation buffer 
alone). (b) Mitochondria incubated with 70 ~M Ca 2+ and 3 mM Pi (CaPi) for 10 min. (c) Mitochondria treated with CaP i plus 0.5 /zM CsA for 20 rain. 
(d) Mitochondria treated with CaP i plus 0.5 mM sulfide for 10 min. (e) Mitochondria treated with CaP, plus 3 /xM oligomycin for 10 min. (f) 
Mitochondria treated with CaP i plus 1 /zM antimycin for 10 min. Magnification =4160 X ; Bar = 5 ~m. 
ity transition fol lowing a 10 min incubation in the presence 
of CaP i. Nearly the entire population of mitochondria has 
undergone large-amplitude swell ing as evidenced by the 
loss in electron density and an increase in size. Addit ion of 
0.5 /zM CsA prevented the CaPi-induced response, as 
shown in Fig. lc fol lowing a 20 min incubation. 
Mitochondrial samples treated for 10 min with CaP i
plus either 0.5 mM sulfide, 3 /zM ol igomycin, or 1 /zM 
antimycin, (Figs. I d - f ,  respectively) do not exhibit large- 
amplitude swell ing as observed with CaP i treatment alone 
(Fig. lb). However, some mitochondria in these popula- 
tions appear somewhat less electron dense than untreated 
mitochondria (Fig. la) and are perhaps in the orthodox 
conformation as opposed to the condensed conformation 
[33]. These two conformations have been studied by Hack- 
enbrock [33], who proposed that they are related to either 
the metabolic state of the mitochondria or the energization 
of the inner mitochondrial membrane. 
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Table 2 
Intra- and extra-mitochondrial pyridine nucleotides 
Expressed nmol/mg 
NADH NAD + NADPH NADP + TOTAL 
*I *E I E I E I E 
Control 
0 min 5.3 0.00 0.53 0.21 3.60 0.15 0.35 0.11 10.25 
5 rain 4.5 0.17 0.69 0.25 3.55 0.23 0.16 0.13 9.68 
CaP i
5 min 2.5 0.13 1.09 1.52 1.38 0.48 0.89 1.04 9.03 
CaP i + CyA 
5 min 4.4 0.13 0.54 0.24 2.49 0.19 0.25 0.09 8.33 
CaP i + oligomycin 
5 min 4.2 0.08 0.96 0.71 2.73 0.00 0.54 0.30 9.52 
CaP, + sulfide 
5 min 3.1 0.12 1.60 0.44 1.79 0.31 1.19 0.28 8.83 
CaP i + antimycin 
5 rain 2.0 0.08 1.74 1.09 1.05 0.25 2.10 0.53 8.84 
* i = intramitochondrial E = extramitochondrial. 
3.2. Effect ~0 ¢ Ca 2+ and Pi on adenine and pyridine 
nucleotides 
CaPi-induced permeability transition is accompanied by 
the rapid and extensive oxidation of NADH and NADPH 
[23]. Since pyridine nucleotides are relatively small 
molecules (< 850 Da) and normally impermeable to the 
inner membrane, we hypothesized that release of pyridine 
nucleotides occurred through the putative inner membrane 
pore. To test this hypothesis, both intra- and extra-mito- 
chondrial NAD(H) and NADP(H) levels were measured 
during permeability ransition induced with CaP~. As shown 
in Table 2, mitochondrial NADH and NADPH pools are 
decreased roughly 50% within 5 min following treatment 
with CaP~. This decrease is not accounted for by an 
increase in extramitochondrial NADH and NADPH (Table 
2). The depletion of NADH and NADPH are nearly ac- 
counted for as NAD + and NADP + which are found both 
intra- and extra-mitochondrially. The addition of 0.5 /zM 
CsA, a potent inhibitor of permeability transition, pre- 
vented the oxidation and release of NAD + and NADP + 
(Table 2). 
As shown in Table 2, the addition of oligomycin (3 
~M), sulfide (0.5 raM) or antimycin (1 p,M) to incubation 
buffer containing CaP i decreased NADH and NADPH to 
varying degrees. Treatment with oligomycin and sulfide 
maintained NADH levels 40% and 20%, respectively, 
greater than CaP~ treatment alone, whereas the addition of 
antimycin potentiated the loss of NADH by 20%. The 
observed loss of NADH and NADPH was not accounted 
for by the recovery of NADH and NADPH extramitochon- 
drially (Table 2). With all treatments, the NADH lost was 
recovered as NAD + and detected both intra- and extra- 
mitochondrially (Table 2). Interestingly, the amount of 
NAD + detected extramitochondrially does not correspond 
to the amount of NADH lost. For example, treatment with 
antimycin resulted in increased formation of NAD + as 
compared to CaP~ treatment alone, although antimycin- 
treated mitochondria released less NAD + (Table 2). 
The mitochondrial NADPH pool followed the same 
pattern of oxidation and release as observed with NADH 
following treatment of mitochondria with the metabolic 
inhibitors. The loss of NADPH was accounted for as 
NADP +, which was recovered both intra- and extramito- 
chondrially (Table 2). The release of NADP + from the 
matrix followed the same pattern as that observed with 
NAD + following a 5 min incubation. The observed pattern 
is that treatment with CaP i resulted in the greatest release 
of NAD + and NADP +, followed by treatment with an- 
timycin + CaP~, oligomycin + CaP i, and then sulfide + 
CaP i. 
Table 1 lists the pyridine nucleotide redox couples of 
NAD+:NADH and NADP+:NADPH following a 5 rain 
incubation. Treatment with CaP i resulted in greatly in- 
creased ratios of both NAD + :NADH and NADP + :NADPH, 
as compared to untreated controls and CsA-treated mito- 
chondrial samples. However, the addition of antimycin to 
CaPi-treated mitochondria resulted in the redox ratios of 
both NAD + :NADH and NADP + :NADPH greater than that 
Table 3 
Alteration of adenosine nucleotides during permeability transition 
Adenosine nucleotides (nmol/mg after incubation for 5 min) 
control control CaP i CaP, + CsA CaP, + CaP, + 
(zero time) (5 min) (0.5/~M) oligomycin antirnycin 
(3.0/~M) (1.0 /zM) 
ATP 
Intra 2.2 1.8 0.9 2.7 2.4 1.0 
Extra 1.7 1.5 0.3 2.9 1.3 0.0 
ADP 
Intra 5.5 5.0 1.8 7.1 4.2 3.0 
Extra 0.4 0.3 1.1 0.4 1.4 0.4 
AMP 
Intra 7.6 8.2 6.6 6.3 5.0 5.6 
Extra 0.4 0.2 6.0 0.1 1.6 5.9 
Total 17.7 17.0 16.7 19.5 15.9 15.9 
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observed with CaP i treatment alone. The addition of 
oligomycin or sulfide to CaPi-treated mitochondria pre- 
served the NAD+:NADH and NADP+:NADPH:redox 
couples as compared to CaP i treatment alone (Table 1). 
Measurements of ATP, ADP, and AMP with the vari- 
ous treatments are reported in Table 3. Treatment with 
CaP~ resulted in the depletion of ATP and ADP by 5 min, 
with 75% of the adenine pool recovered as AMP (Table 3). 
Addition of 0.5 /zM CsA eliminated this effect, resulting 
in increased levels of ATP, slightly increased levels of 
ADP, and decreased AMP levels compared to untreated 
control samples (Table 3). 
The presence of the metabolic inhibitors in addition to 
CaP i preserved ATP and/or ADP levels compared to CaP i
treatment alone (Table 3). The addition of 3 /xM 
oligomycin to CaPi-treated mitochondria maintained ATP 
levels similar to control values at 5 min, whereas ADP loss 
was minimal as compared to CaP~ treatment alone. The 
addition of antimycin (1 /zM), in conjunction with CaP i, 
did not sustain ATP levels any differently than did CaP~ 
treatment alone; however, ADP levels were preserved as 
compared to CaP i treatment alone (Table 3). 
The energy charge [(ATP + 0.5ADP)/(ATP + ADP + 
AMP)], which is one designation of energy status, indi- 
cated that the presence of antimycin, sulfide, or oligomycin 
preserved mitochondrial energy to varying degrees com- 
pared to CaP~ treatment alone. Following treatment with 
CaP i, the energy charge dropped to 0.158 as compared to 
untreated controls (0.351) (Table 1). Treatment of mito- 
chondria with either oligomycin, sulfide, or antimycin plus 
CaP~ resulted in energy charge values of 0.409, 0.209 and 
0.169 respectively, following a 5 min incubation (Table 1). 
4. Discussion 
A major finding is the dissociation of inner membrane 
permeability transition from large-amplitude swelling. As 
large-amplitude swelling results from the permeabilization 
of the inner membrane, it is often used to assess whether 
permeability transition is occurring in mitochondrial sam- 
ples. As a secondary event to the permeability transition, 
large-amplitude swelling is thought o occur because ma- 
trix proteins are slow to equilibrate through the permeabil- 
ity defect as compared with smaller solutes. This is thought 
to create a colloid-osmotic pressure imbalance which drives 
the entrance of water, resulting in dilution of the matrix 
and massive swelling [18]. 
Several previous reports have suggested that both an- 
timycin and oligomycin inhibit permeability transition 
[34-37]. These conclusions are based upon the ability of 
these compounds to prevent large-amplitude swelling. We 
have recently demonstrated [27] that, although these com- 
pounds do prevent large-amplitude swelling, release of 
both matrix GSH and Ca 2+ occurred by a CsA-sensitive 
mechanism. This occurred when either antimycin, 
oligomycin, or sulfide were coincubated in buffer contain- 
ing CaP i (Table 1). Under these conditions, the addition of 
CsA completely prevented GSH, as well as Ca 2÷ release 
[27]. The prevention by CsA, a potent inhibitor of the 
permeability transition, suggested that inner membrane 
permeability occurred in the absence of large-amplitude 
swelling. 
Analysis of mitochondrial samples by TEM also indi- 
cated that the morphological terations observed with CaP i
treatment are prevented when metabolic inhibitors are 
present (Figs. l a-f). These findings suggest hat severe 
mitochondrial injury, such as the loss of matrix GSH, can 
occur without obvious morphological changes and, there- 
fore, that it may be necessary to monitor solute release 
rather than relying solely on ultrastructural nalysis such 
as TEM or light scatter changes at 540 nm to assess inner 
membrane permeability. 
Mitochondria treated with oligomycin, antimycin, or 
sulfide in buffer containing CaP i appear to be in the 
orthodox conformation as opposed to the condensed (Figs. 
ld- f )  [33]. Changes in ultrastructure from the condensed 
to the orthodox conformation are generally associated with 
a decrease in mitochondrial energy status [33]. Mitochon- 
drial energy status is regulated by several different parame- 
ters including adenine and pyridine nucleotides, the ratio 
of GSH:GSSG as well as the ratio of total thiols:total 
disulfides and the membrane potential. Recent publications 
[27,40-42] suggest that the collapse of the membrane 
potential is closely linked with permeability transition. 
Other studies have also suggested that membrane potential 
is important in regulating inner membrane permeability 
[38-40]. 
We have observed that CaP~-induced permeability tran- 
sition was accompanied by the oxidation of the pyridine 
nucleotide pool and depletion of ATP [26], with the selec- 
tive efflux of NAD ÷ and NADP ÷. These findings do not 
Support he current hought hat CaPi-induced permeability 
transition does not alter the status of pyridine or adenine 
nucleotides. Although the mechanism by which CaP~ treat- 
ment results in the oxidation of NADH and NADPH is not 
understood, it does not appear to involve the oxidation of 
GSH or lipid peroxidation, as no evidence of either has 
been detected in this model [15]. 
We also measured the status of pyridine and adenine 
nucleotide in mitochondria treated with either oligomycin, 
sulfide or antimycin in the presence of CaPi. The addition 
of oligomycin, sulfide or antimycin to CaPctreated mito- 
chondria prevented mitochondrial large-amplitude swelling 
but not the CsA-sensitive release of GSH and Ca 2÷ [27]. 
Treatment of mitochondria with oligomycin or sulfide in 
the presence of CaP i preserved the reduce pyridine nu- 
cleotide levels as compared CaP~ alone, but less than 
untreated control samples. On the other hand, antimycin, in 
the presence of CaP~, potentiated the decrease in pyridine 
nucleotides. 
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The increased oxidation of NADH and NADPH ob- 
served with antimycin treatment may be due to an increase 
in H202. Inhibition of electron transport with antimycin is 
thought o result in an increase in H202 formation due to 
the electron leakage at ubiquinone [43,44]. However, for- 
mation of GSSG was not detected and GSH was released 
to the extramitochondrial environment within 5 rain. 
Inducing agents such as t-butyl hydroperoxide or hy- 
drogen peroxide are thought o induce permeability transi- 
tion due to the oxidation of pyridine nucleotides [18,41,45]. 
However, based on the findings we report, the redox status 
of pyridine nucleotides alone does not seem to regulate 
permeability transition. This observation is based on the 
finding that treatment with antimycin resulted in an in- 
creased oxidation of both NADH and NADPH compared 
to CaP i treatment alone; but, unlike CaP i treatment, he 
addition of antimycin abolished large-amplitude swelling 
and solute release was diminished. Although these findings 
do not dispute the significance of the pyridine nucleotide 
redox status in contributing to or regulating permeability 
transition, they do seem to suggest that pyridine nucleotide 
redox status alone does not determine the degree of perme- 
ability transition status, i.e., permeability transition with or 
without large-amplitude swelling. 
In conclusion, we report that during CaPi-induced per- 
meability transition, NADH, NADPH, ATP and ADP are 
rapidly depleted. Our findings suggest that inner mem- 
brane permeability transition can occur in the absence of 
mitochondrial arge-amplitude swelling. We find that 
CsA-sensitive permeability transition can occur without 
large-amplitude swelling and that under these conditions, 
the loss of solute regulation of GSH, Ca 2+ [27], and 
perhaps other matrix solutes, is indicated by the release of 
these molecules. Ultrastructural analysis of mitochondria 
by TEM or light scatter did not indicate the significant 
biochemical alterations occurring under the conditions 
studied. This observation may be important, because mito- 
chondrial integrity is often assessed by TEM and the light 
scatter assay. We conclude that CsA-sensitive permeability 
transition occurs without obvious ultrastructural changes. 
Therefore, monitoring the CsA-sensitive release of concen- 
trated endogenous matrix solutes, such as GSH, may be a 
sensitive and useful indicator of mitochondrial permeabil- 
ity transition. Under these conditions, NADH and NADPH 
undergo extensive oxidation with the subsequent release of 
NAD + and NADP + from the mitochondrial matrix within 
a 5 rain incubation. This release appears to occur through 
the putative Ca2+-dependent i ner membrane pore as CsA 
prevented the oxidation and release of pyridine nu- 
cleotides. ATP and ADP are also rapidly depleted with the 
concomitant formation of AMP during CaP i treatment. The 
addition of either oligomycin, sulfide, or antimycin pre- 
served NADH, NADPH, ATP, and ADP to varying de- 
grees. 
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